The association between urine neutrophil gelatinase-associated lipocalin and UTI in people with neurogenic lower urinary tract dysfunction

Study design Secondary analysis of urine samples collected from a prospective within-subject clinical trial. Objectives Describe the baseline variation in urine neutrophil gelatinase-associated lipocalin (uNGAL) levels in adults with neurogenic lower urinary tract dysfunction (NLUTD) and determine i...

Full description

Saved in:
Bibliographic Details
Published inSpinal cord Vol. 59; no. 9; pp. 959 - 966
Main Authors Forster, Catherine S., Lamanna, Olivia K., Rounds, Amanda, Sprague, Bruce M., Ljungberg, Inger, Groah, Suzanne L.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.09.2021
Nature Publishing Group
Subjects
Online AccessGet full text
ISSN1362-4393
1476-5624
1476-5624
DOI10.1038/s41393-020-00552-x

Cover

Loading…
Abstract Study design Secondary analysis of urine samples collected from a prospective within-subject clinical trial. Objectives Describe the baseline variation in urine neutrophil gelatinase-associated lipocalin (uNGAL) levels in adults with neurogenic lower urinary tract dysfunction (NLUTD) and determine if uNGAL levels vary according to likelihood of having a UTI. Setting Greater Washington D.C. region. Methods Urine samples were collected from a cohort of adults with NLUTD from a clinical trial. Samples were divided into groups of “Not UTI”, “Unlikely UTI”, and “Likely UTI” based on symptoms and urine culture results. uNGAL was compared between groups using Kruskal–Wallis and post hoc Dunn’s test. Mixed effects logistic model was used to assess the association of uNGAL and Likely UTI. Results Twenty-seven participants provided a total of 104 samples. uNGAL levels were lowest for the No UTI group ( n  = 29; 37 ng/ml interquartile range (IQR) (15, 71)), intermediate for the Unlikely UTI group ( n  = 67; 95 ng/ml IQR (37, 161)) and highest for the Likely UTI group ( n  = 8; 187 ng/ml IQR(146, 224)). uNGAL levels were higher in those with Likely UTI compared to both Unlikely UTI ( p  < 0.05) and No UTI ( p  < 0.01). uNGAL had an association with Likely UTI (OR 1.01, 95% CI (1.00–1.02), p  = 0.049). Conclusions Adults with NLUTD have notable variation in uNGAL levels in the absence of symptoms potentially due to UTI. uNGAL levels are higher in those who are likely to have UTI have higher uNGAL levels compared to those with non-specific symptoms and/or less growth on urine culture. uNGAL may have utility as a marker of UTI in people with NLUTD. Sponsorship Patient-Centered Outcomes Research Institute (PCORI) funded this work. Bioporto provided partial salary support for SLG, IL, and OKL. NGAL ELISAs were provided by Bioporto in kind.
AbstractList Study design Secondary analysis of urine samples collected from a prospective within-subject clinical trial. Objectives Describe the baseline variation in urine neutrophil gelatinase-associated lipocalin (uNGAL) levels in adults with neurogenic lower urinary tract dysfunction (NLUTD) and determine if uNGAL levels vary according to likelihood of having a UTI. Setting Greater Washington D.C. region. Methods Urine samples were collected from a cohort of adults with NLUTD from a clinical trial. Samples were divided into groups of “Not UTI”, “Unlikely UTI”, and “Likely UTI” based on symptoms and urine culture results. uNGAL was compared between groups using Kruskal–Wallis and post hoc Dunn’s test. Mixed effects logistic model was used to assess the association of uNGAL and Likely UTI. Results Twenty-seven participants provided a total of 104 samples. uNGAL levels were lowest for the No UTI group ( n  = 29; 37 ng/ml interquartile range (IQR) (15, 71)), intermediate for the Unlikely UTI group ( n  = 67; 95 ng/ml IQR (37, 161)) and highest for the Likely UTI group ( n  = 8; 187 ng/ml IQR(146, 224)). uNGAL levels were higher in those with Likely UTI compared to both Unlikely UTI ( p  < 0.05) and No UTI ( p  < 0.01). uNGAL had an association with Likely UTI (OR 1.01, 95% CI (1.00–1.02), p  = 0.049). Conclusions Adults with NLUTD have notable variation in uNGAL levels in the absence of symptoms potentially due to UTI. uNGAL levels are higher in those who are likely to have UTI have higher uNGAL levels compared to those with non-specific symptoms and/or less growth on urine culture. uNGAL may have utility as a marker of UTI in people with NLUTD. Sponsorship Patient-Centered Outcomes Research Institute (PCORI) funded this work. Bioporto provided partial salary support for SLG, IL, and OKL. NGAL ELISAs were provided by Bioporto in kind.
Study designSecondary analysis of urine samples collected from a prospective within-subject clinical trial.ObjectivesDescribe the baseline variation in urine neutrophil gelatinase-associated lipocalin (uNGAL) levels in adults with neurogenic lower urinary tract dysfunction (NLUTD) and determine if uNGAL levels vary according to likelihood of having a UTI.SettingGreater Washington D.C. region.MethodsUrine samples were collected from a cohort of adults with NLUTD from a clinical trial. Samples were divided into groups of “Not UTI”, “Unlikely UTI”, and “Likely UTI” based on symptoms and urine culture results. uNGAL was compared between groups using Kruskal–Wallis and post hoc Dunn’s test. Mixed effects logistic model was used to assess the association of uNGAL and Likely UTI.ResultsTwenty-seven participants provided a total of 104 samples. uNGAL levels were lowest for the No UTI group (n = 29; 37 ng/ml interquartile range (IQR) (15, 71)), intermediate for the Unlikely UTI group (n = 67; 95 ng/ml IQR (37, 161)) and highest for the Likely UTI group (n = 8; 187 ng/ml IQR(146, 224)). uNGAL levels were higher in those with Likely UTI compared to both Unlikely UTI (p < 0.05) and No UTI (p < 0.01). uNGAL had an association with Likely UTI (OR 1.01, 95% CI (1.00–1.02), p = 0.049).ConclusionsAdults with NLUTD have notable variation in uNGAL levels in the absence of symptoms potentially due to UTI. uNGAL levels are higher in those who are likely to have UTI have higher uNGAL levels compared to those with non-specific symptoms and/or less growth on urine culture. uNGAL may have utility as a marker of UTI in people with NLUTD.SponsorshipPatient-Centered Outcomes Research Institute (PCORI) funded this work. Bioporto provided partial salary support for SLG, IL, and OKL. NGAL ELISAs were provided by Bioporto in kind.
Secondary analysis of urine samples collected from a prospective within-subject clinical trial.STUDY DESIGNSecondary analysis of urine samples collected from a prospective within-subject clinical trial.Describe the baseline variation in urine neutrophil gelatinase-associated lipocalin (uNGAL) levels in adults with neurogenic lower urinary tract dysfunction (NLUTD) and determine if uNGAL levels vary according to likelihood of having a UTI.OBJECTIVESDescribe the baseline variation in urine neutrophil gelatinase-associated lipocalin (uNGAL) levels in adults with neurogenic lower urinary tract dysfunction (NLUTD) and determine if uNGAL levels vary according to likelihood of having a UTI.Greater Washington D.C. region.SETTINGGreater Washington D.C. region.Urine samples were collected from a cohort of adults with NLUTD from a clinical trial. Samples were divided into groups of "Not UTI", "Unlikely UTI", and "Likely UTI" based on symptoms and urine culture results. uNGAL was compared between groups using Kruskal-Wallis and post hoc Dunn's test. Mixed effects logistic model was used to assess the association of uNGAL and Likely UTI.METHODSUrine samples were collected from a cohort of adults with NLUTD from a clinical trial. Samples were divided into groups of "Not UTI", "Unlikely UTI", and "Likely UTI" based on symptoms and urine culture results. uNGAL was compared between groups using Kruskal-Wallis and post hoc Dunn's test. Mixed effects logistic model was used to assess the association of uNGAL and Likely UTI.Twenty-seven participants provided a total of 104 samples. uNGAL levels were lowest for the No UTI group (n = 29; 37 ng/ml interquartile range (IQR) (15, 71)), intermediate for the Unlikely UTI group (n = 67; 95 ng/ml IQR (37, 161)) and highest for the Likely UTI group (n = 8; 187 ng/ml IQR(146, 224)). uNGAL levels were higher in those with Likely UTI compared to both Unlikely UTI (p < 0.05) and No UTI (p < 0.01). uNGAL had an association with Likely UTI (OR 1.01, 95% CI (1.00-1.02), p = 0.049).RESULTSTwenty-seven participants provided a total of 104 samples. uNGAL levels were lowest for the No UTI group (n = 29; 37 ng/ml interquartile range (IQR) (15, 71)), intermediate for the Unlikely UTI group (n = 67; 95 ng/ml IQR (37, 161)) and highest for the Likely UTI group (n = 8; 187 ng/ml IQR(146, 224)). uNGAL levels were higher in those with Likely UTI compared to both Unlikely UTI (p < 0.05) and No UTI (p < 0.01). uNGAL had an association with Likely UTI (OR 1.01, 95% CI (1.00-1.02), p = 0.049).Adults with NLUTD have notable variation in uNGAL levels in the absence of symptoms potentially due to UTI. uNGAL levels are higher in those who are likely to have UTI have higher uNGAL levels compared to those with non-specific symptoms and/or less growth on urine culture. uNGAL may have utility as a marker of UTI in people with NLUTD.CONCLUSIONSAdults with NLUTD have notable variation in uNGAL levels in the absence of symptoms potentially due to UTI. uNGAL levels are higher in those who are likely to have UTI have higher uNGAL levels compared to those with non-specific symptoms and/or less growth on urine culture. uNGAL may have utility as a marker of UTI in people with NLUTD.Patient-Centered Outcomes Research Institute (PCORI) funded this work. Bioporto provided partial salary support for SLG, IL, and OKL. NGAL ELISAs were provided by Bioporto in kind.SPONSORSHIPPatient-Centered Outcomes Research Institute (PCORI) funded this work. Bioporto provided partial salary support for SLG, IL, and OKL. NGAL ELISAs were provided by Bioporto in kind.
Author Lamanna, Olivia K.
Ljungberg, Inger
Forster, Catherine S.
Sprague, Bruce M.
Rounds, Amanda
Groah, Suzanne L.
AuthorAffiliation 5. MedStar Georgetown University Hospital, Washington, DC, 20057
1. Biomedical Research Institute, Rockville, MD 20850
3. MedStar National Rehabilitation Hospital, Washington, D.C, 20010
2. Children’s National Hospital, Washington, D.C., 20010
4. MedStar Health Research Institute, Hyattsville, MD 20783
AuthorAffiliation_xml – name: 4. MedStar Health Research Institute, Hyattsville, MD 20783
– name: 1. Biomedical Research Institute, Rockville, MD 20850
– name: 5. MedStar Georgetown University Hospital, Washington, DC, 20057
– name: 2. Children’s National Hospital, Washington, D.C., 20010
– name: 3. MedStar National Rehabilitation Hospital, Washington, D.C, 20010
Author_xml – sequence: 1
  givenname: Catherine S.
  orcidid: 0000-0002-6233-1070
  surname: Forster
  fullname: Forster, Catherine S.
  email: forstercs@upmc.edu
  organization: Biomedical Research Institute, Children’s National Hospital, UPMC Children’s Hospital of Pittsburgh
– sequence: 2
  givenname: Olivia K.
  surname: Lamanna
  fullname: Lamanna, Olivia K.
  organization: Biomedical Research Institute, Children’s National Hospital
– sequence: 3
  givenname: Amanda
  surname: Rounds
  fullname: Rounds, Amanda
  organization: MedStar National Rehabilitation Hospital, MedStar Health Research Institute
– sequence: 4
  givenname: Bruce M.
  surname: Sprague
  fullname: Sprague, Bruce M.
  organization: Children’s National Hospital
– sequence: 5
  givenname: Inger
  surname: Ljungberg
  fullname: Ljungberg, Inger
  organization: MedStar National Rehabilitation Hospital, MedStar Health Research Institute
– sequence: 6
  givenname: Suzanne L.
  orcidid: 0000-0003-1213-1959
  surname: Groah
  fullname: Groah, Suzanne L.
  organization: MedStar National Rehabilitation Hospital, MedStar Georgetown University Hospital
BookMark eNp9kUtv1DAUhS1URB_wB1hZYsMmxY_YSVYIVTwqVWIzrC3Hvp5x5bGDnTDtX-BX45lpQXTRla90v3Pusc45OokpAkJvKbmkhPcfSkv5wBvCSEOIEKy5e4HOaNvJRkjWntSZS9a0lTlF56XcEkIGOvSv0Clng-R1eYZ-rzaAdSnJeD37FPEI8w4g4iX7CDjCMuc0bXzAawiViLpA88iDxcFPyejgI9bR4h-ra1zHCdIUAO_8vNk75LSG6A0OaQf5YKzzPZ6zNjO298Ut0exPv0YvnQ4F3jy8F2j15fPq6ltz8_3r9dWnm8a0gs0No86Cpr3hjko2DtY5041Ae6altdKKru-15lSLHoCDBTOOmlpr3OiE1fwCfTzaTsu4BWsg1iRBTdlvayyVtFf_b6LfqHX6pSjtCGMdqQ7vHxxy-rlAmdXWFwMh6AhpKYq1rWiZrB1U9N0T9DYtOdbvKSakYF3HO1YpdqRMTqVkcH_TUKL2Vatj1apWrQ5Vq7sq6p-IjJ8PHdbUPjwv5UdpqXfiGvK_VM-o_gDEPMWk
CitedBy_id crossref_primary_10_1007_s00467_024_06321_9
crossref_primary_10_1038_s41393_021_00683_9
crossref_primary_10_3389_fped_2024_1368583
crossref_primary_10_3390_diagnostics13030468
crossref_primary_10_1177_11772719221144459
Cites_doi 10.1016/j.clinbiochem.2015.08.003
10.1002/jcla.21962
10.1038/ki.2012.195
10.1007/s00467-009-1279-6
10.1186/1479-5876-10-174
10.1016/j.jbi.2008.08.010
10.1681/ASN.2006080882
10.1016/j.juro.2016.01.088
10.1007/s00467-011-1856-3
10.1016/j.ajic.2014.02.003
10.1016/j.apmr.2017.10.005
10.1016/j.jpurol.2018.12.008
10.7326/0003-4819-148-11-200806030-00003
10.1128/JCM.05852-11
10.1007/s00467-014-2905-5
10.2340/16501977-1207
10.1007/s00467-018-3936-0
10.1371/journal.pone.0171114
10.1172/JCI71630
10.1016/j.juro.2013.12.013
10.1310/sci2503-214
10.1016/S0003-9993(95)80615-6
10.1038/sc.2013.77
10.1086/650482
10.1371/journal.pone.0197568
10.1681/ASN.2009010065
ContentType Journal Article
Copyright The Author(s), under exclusive licence to International Spinal Cord Society 2020
The Author(s), under exclusive licence to International Spinal Cord Society 2020.
2020. The Author(s), under exclusive licence to International Spinal Cord Society.
Copyright_xml – notice: The Author(s), under exclusive licence to International Spinal Cord Society 2020
– notice: The Author(s), under exclusive licence to International Spinal Cord Society 2020.
– notice: 2020. The Author(s), under exclusive licence to International Spinal Cord Society.
DBID AAYXX
CITATION
3V.
7QL
7RV
7T7
7TK
7U9
7X7
7XB
88E
8AO
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB0
LK8
M0S
M1P
M7N
M7P
NAPCQ
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1038/s41393-020-00552-x
DatabaseName CrossRef
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Nursing & Allied Health Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Virology and AIDS Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
ProQuest Central Student
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: BENPR
  name: ProQuest Central - New (Subscription)
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1476-5624
EndPage 966
ExternalDocumentID PMC11702270
10_1038_s41393_020_00552_x
GrantInformation_xml – fundername: Patient-Centered Outcomes Research Institute (PCORI)
  grantid: AD-1310-08215; AD-1310-08215; AD-1310-08215
  funderid: https://doi.org/10.13039/100006093
– fundername: OL received partial salary support from Bioporto. NGAL ELISAS were provided in kind by Bioport
– fundername: IL received partial salary support from Bioporto
GroupedDBID ---
-Q-
.GJ
0R~
123
2QV
2WC
36B
39C
3V.
4.4
406
53G
5BI
5RE
6PF
70F
7RV
7X7
88E
8AO
8FI
8FJ
8R4
8R5
AACDK
AANZL
AASML
AATNV
AAWTL
AAYZH
AAZLF
ABAKF
ABAWZ
ABDBF
ABJNI
ABLJU
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACMJI
ACPRK
ACRQY
ACUHS
ACZOJ
ADBBV
ADFRT
ADHDB
AEFQL
AEJRE
AEMSY
AENEX
AEVLU
AEXYK
AFBBN
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AIGIU
AILAN
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AXYYD
B0M
BAWUL
BBNVY
BENPR
BHPHI
BKEYQ
BKKNO
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
DIK
DNIVK
DPUIP
DU5
DXH
E3Z
EAD
EAP
EAS
EBC
EBD
EBLON
EBS
EE.
EHN
EIOEI
EJD
EMB
EMK
EMOBN
ENB
ENC
ENX
EPL
EPT
ESX
EX3
F5P
FDQFY
FERAY
FIGPU
FIZPM
FSGXE
FYUFA
HCIFZ
HMCUK
HZ~
IWAJR
JSO
KQ8
LGEZI
LOTEE
M1P
M7P
NADUK
NAO
NAPCQ
NQJWS
NXXTH
O9-
OK1
P2P
PCD
PQQKQ
PROAC
PSQYO
Q2X
Q~Q
RNS
RNT
RNTTT
ROL
SNX
SNYQT
SOJ
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TR2
TUS
UKHRP
W2D
WH7
WOW
ZGI
ZXP
~8M
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
AEZWR
AFDZB
AFHIU
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
JZLTJ
PHGZM
PHGZT
7QL
7T7
7TK
7U9
7XB
8FD
8FE
8FH
8FK
ABRTQ
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
LK8
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c452t-21fdea18c3f162b9dffc7be182a6dd6d5788aa31a58ee3edecbba1ddcfbf5da3
IEDL.DBID 7X7
ISSN 1362-4393
1476-5624
IngestDate Thu Aug 21 18:34:51 EDT 2025
Tue Aug 05 11:10:33 EDT 2025
Sat Aug 23 13:31:33 EDT 2025
Thu Apr 24 22:50:22 EDT 2025
Tue Jul 01 01:16:16 EDT 2025
Fri Feb 21 02:38:01 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
License Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c452t-21fdea18c3f162b9dffc7be182a6dd6d5788aa31a58ee3edecbba1ddcfbf5da3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Authors’ Contributions: CSF was responsible for study design, analyzing the data, interpreting the data, and wrote the first draft of the manuscript. OKL was responsible for running the assays, interpreting the data, and provided critical feedback on the manuscript. AR and IL consented the participants, collected the urine samples, collected symptom data, and provided critical feedback on the manuscript. BS performed the first step of urine processing, collected the symptom data, provided data management, and provided critical feedback on the manuscript. SG was responsible for study design, data interpretation, and provided critical feedback on the manuscript.
ORCID 0000-0002-6233-1070
0000-0003-1213-1959
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC11702270
PMID 32963362
PQID 2565277372
PQPubID 38130
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11702270
proquest_miscellaneous_2445426624
proquest_journals_2565277372
crossref_primary_10_1038_s41393_020_00552_x
crossref_citationtrail_10_1038_s41393_020_00552_x
springer_journals_10_1038_s41393_020_00552_x
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-09-01
PublicationDateYYYYMMDD 2021-09-01
PublicationDate_xml – month: 09
  year: 2021
  text: 2021-09-01
  day: 01
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Spinal cord
PublicationTitleAbbrev Spinal Cord
PublicationYear 2021
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Gupta, Preece, Haynes, Becknell, Ching (CR16) 2019; 25
Nickolas, Forster, Sise, Barasch, Valle, Viltard (CR12) 2012; 82
Rabadi, Mayanna, Vincent (CR21) 2013; 51
Tractenberg, Groah, Rounds, Ljungberg, Schladen (CR9) 2018; 13
Fouts, Pieper, Szpakowski, Pohl, Knoblach, Suh (CR6) 2012; 10
Lee, Kim, Kang, Park (CR14) 2015; 30
Gribble, Puterman, McCallum (CR4) 1989; 70
CR13
Harris, Taylor, Thielke, Payne, Gonzalez, Conde (CR19) 2009; 42
Yilmaz, Sevketoglu, Gedikbasi, Karyagar, Kiyak, Mulazimoglu (CR26) 2009; 24
Nickolas, O’Rourke, Yang, Sise, Canetta, Barasch (CR10) 2008; 148
Schmidt-Ott, Mori, Li, Kalandadze, Cohen, Devarajan (CR25) 2007; 18
Cardenas, Hooton (CR1) 1995; 76
Krzeminska, Wyczalkowska-Tomasik, Korytowska, Paczek (CR23) 2016; 30
Wolfe, Toh, Shibata, Rong, Kenton, FitzGerald (CR7) 2012; 50
Paragas, Kulkarni, Werth, Schmidt-Ott, Forster, Deng (CR24) 2014; 124
Adriaansen, Post, de Groot, van Asbeck, Stolwijk-Swüste, Tepper (CR2) 2013; 45
Forster, Jackson, Ma, Bennett, Shah, Goldstein (CR17) 2018; 33
Makris, Stefani, Makri, Panagou, Lagiou, Sarli (CR11) 2015; 48
Trautner, Petersen, Hysong, Horwitz, Kelly, Naik (CR22) 2014; 42
Chaudhry, Madden-Fuentes, Ortiz, Balsara, Tang, Nseyo (CR18) 2014; 191
Hooton, Bradley, Cardenas, Colgan, Geerlings, Rice (CR3) 2010; 50
Groah, Pérez-Losada, Caldovic, Ljungberg, Sprague, Castro-Nallar (CR5) 2016; 196
Skelton, Grigoryan, Holmes, Poon, Trautner (CR8) 2018; 99
Tractenberg, Garver, Ljungberg, Schladen, Groah (CR20) 2017; 12
Forster, Goldstein, Pohl, Jackson (CR27) 2019; 15
Hatipoglu, Sevketoglu, Gedikbasi, Yilmaz, Kiyak, Mulazimoglu (CR15) 2011; 26
DD Cardenas (552_CR1) 1995; 76
SL Groah (552_CR5) 2016; 196
A Yilmaz (552_CR26) 2009; 24
MJ Gribble (552_CR4) 1989; 70
MH Rabadi (552_CR21) 2013; 51
S Hatipoglu (552_CR15) 2011; 26
CS Forster (552_CR27) 2019; 15
F Skelton (552_CR8) 2018; 99
KM Schmidt-Ott (552_CR25) 2007; 18
E Krzeminska (552_CR23) 2016; 30
RE Tractenberg (552_CR9) 2018; 13
BW Trautner (552_CR22) 2014; 42
TM Hooton (552_CR3) 2010; 50
TL Nickolas (552_CR12) 2012; 82
AJ Wolfe (552_CR7) 2012; 50
RE Tractenberg (552_CR20) 2017; 12
N Paragas (552_CR24) 2014; 124
R Chaudhry (552_CR18) 2014; 191
CS Forster (552_CR17) 2018; 33
552_CR13
HE Lee (552_CR14) 2015; 30
TL Nickolas (552_CR10) 2008; 148
DE Fouts (552_CR6) 2012; 10
S Gupta (552_CR16) 2019; 25
JJE Adriaansen (552_CR2) 2013; 45
PA Harris (552_CR19) 2009; 42
K Makris (552_CR11) 2015; 48
References_xml – volume: 48
  start-page: 1291
  year: 2015
  end-page: 7
  ident: CR11
  article-title: Evaluation of a particle enhanced turbidimetric assay for the measurement of neutrophil gelatinase-associated lipocalin in plasma and urine on Architect-8000: analytical performance and establishment of reference values
  publication-title: Clin Biochem
  doi: 10.1016/j.clinbiochem.2015.08.003
– volume: 30
  start-page: 956
  year: 2016
  end-page: 60
  ident: CR23
  article-title: Comparison of two methods for determination of NGAL levels in urine: ELISA and CMIA
  publication-title: J Clin Lab Anal
  doi: 10.1002/jcla.21962
– volume: 82
  start-page: 718
  year: 2012
  end-page: 22.
  ident: CR12
  article-title: NGAL (Lcn2) monomer is associated with tubulointerstitial damage in chronic kidney disease
  publication-title: Kidney Int
  doi: 10.1038/ki.2012.195
– volume: 24
  start-page: 2387
  year: 2009
  end-page: 92
  ident: CR26
  article-title: Early prediction of urinary tract infection with urinary neutrophil gelatinase associated lipocalin
  publication-title: Pediatr Nephrol
  doi: 10.1007/s00467-009-1279-6
– volume: 10
  year: 2012
  ident: CR6
  article-title: Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury
  publication-title: J Transl Med
  doi: 10.1186/1479-5876-10-174
– volume: 42
  start-page: 377
  year: 2009
  end-page: 81.
  ident: CR19
  article-title: Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support
  publication-title: J Biomed Inf
  doi: 10.1016/j.jbi.2008.08.010
– volume: 18
  start-page: 407
  year: 2007
  end-page: 13.
  ident: CR25
  article-title: Dual action of neutrophil gelatinase-associated lipocalin
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2006080882
– volume: 196
  start-page: 579
  year: 2016
  end-page: 87
  ident: CR5
  article-title: Redefining healthy urine: a cross-sectional exploratory metagenomic study of people with and without bladder dysfunction
  publication-title: J Urol
  doi: 10.1016/j.juro.2016.01.088
– volume: 26
  start-page: 1263
  year: 2011
  end-page: 8
  ident: CR15
  article-title: Urinary MMP-9/NGAL complex in children with acute cystitis
  publication-title: Pediatr Nephrol
  doi: 10.1007/s00467-011-1856-3
– volume: 42
  start-page: 653
  year: 2014
  end-page: 8
  ident: CR22
  article-title: Overtreatment of asymptomatic bacteriuria: Identifying provider barriers to evidence-based care
  publication-title: Am J Infect Control
  doi: 10.1016/j.ajic.2014.02.003
– volume: 99
  start-page: 219
  year: 2018
  end-page: 25
  ident: CR8
  article-title: Routine urine testing at the spinal cord injury annual evaluation leads to unnecessary antibiotic use: a pilot study and future directions
  publication-title: Arch Phys Med Rehabil
  doi: 10.1016/j.apmr.2017.10.005
– volume: 15
  start-page: 155.e1
  year: 2019
  end-page: 6
  ident: CR27
  article-title: Association between urodynamic parameters and urine neutrophil gelatinase–associated lipocalin concentrations in children with neuropathic bladders
  publication-title: J Pediatr Urol
  doi: 10.1016/j.jpurol.2018.12.008
– volume: 148
  start-page: 810
  year: 2008
  end-page: 9
  ident: CR10
  article-title: Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-148-11-200806030-00003
– volume: 50
  start-page: 1376
  year: 2012
  end-page: 83
  ident: CR7
  article-title: Evidence of uncultivated bacteria in the adult female bladder
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.05852-11
– volume: 30
  start-page: 123
  year: 2015
  end-page: 30
  ident: CR14
  article-title: The diagnosis of febrile urinary tract infection in children may be facilitated by urinary biomarkers
  publication-title: Pediatr Nephrol
  doi: 10.1007/s00467-014-2905-5
– volume: 45
  start-page: 1016
  year: 2013
  end-page: 22
  ident: CR2
  article-title: Secondary health conditions in persons with spinal cord injury: a longitudinal study from one to five years post-discharge
  publication-title: J Rehabil Med
  doi: 10.2340/16501977-1207
– volume: 33
  start-page: 1365
  year: 2018
  end-page: 74
  ident: CR17
  article-title: Predictive ability of NGAL in identifying urinary tract infection in children with neurogenic bladders
  publication-title: Pediatr Nephrol
  doi: 10.1007/s00467-018-3936-0
– ident: CR13
– volume: 12
  start-page: e0171114
  year: 2017
  ident: CR20
  article-title: Maintaining primacy of the patient perspective in the development of patient-centered patient reported outcomes
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0171114
– volume: 124
  start-page: 2963
  year: 2014
  end-page: 76
  ident: CR24
  article-title: α-Intercalated cells defend the urinary system from bacterial infection
  publication-title: J Clin Invest
  doi: 10.1172/JCI71630
– volume: 191
  start-page: 1454
  year: 2014
  end-page: 61.
  ident: CR18
  article-title: Inflammatory response to Escherichia coli urinary tract infection in the neurogenic bladder of the spinal cord injured host
  publication-title: J Urol
  doi: 10.1016/j.juro.2013.12.013
– volume: 25
  start-page: 214
  year: 2019
  end-page: 21
  ident: CR16
  article-title: Differentiating asymptomatic bacteriuria from urinary tract infection in the pediatric neurogenic bladder population: NGAL as a promising biomarker
  publication-title: Top Spinal Cord Inj Rehabil
  doi: 10.1310/sci2503-214
– volume: 76
  start-page: 272
  year: 1995
  end-page: 80
  ident: CR1
  article-title: Urinary tract infection in persons with spinal cord injury
  publication-title: Arch Phys Med Rehabil
  doi: 10.1016/S0003-9993(95)80615-6
– volume: 51
  start-page: 784
  year: 2013
  end-page: 8
  ident: CR21
  article-title: Predictors of mortality in veterans with traumatic spinal cord injury
  publication-title: Spinal Cord
  doi: 10.1038/sc.2013.77
– volume: 50
  start-page: 625
  year: 2010
  end-page: 63.
  ident: CR3
  article-title: Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America
  publication-title: Clin Infect Dis
  doi: 10.1086/650482
– volume: 70
  start-page: 376
  year: 1989
  end-page: 9
  ident: CR4
  article-title: Pyuria: its relationship to bacteriuria in spinal cord injured patients on intermittent catheterization
  publication-title: Arch Phys Med Rehabil
– volume: 13
  start-page: e0197568
  year: 2018
  ident: CR9
  article-title: Preliminary validation of a Urinary Symptom Questionnaire for individuals with Neuropathic Bladder using Intermittent Catheterization (USQNB-IC): a patient-centered patient reported outcome
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0197568
– volume: 196
  start-page: 579
  year: 2016
  ident: 552_CR5
  publication-title: J Urol
  doi: 10.1016/j.juro.2016.01.088
– volume: 148
  start-page: 810
  year: 2008
  ident: 552_CR10
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-148-11-200806030-00003
– volume: 48
  start-page: 1291
  year: 2015
  ident: 552_CR11
  publication-title: Clin Biochem
  doi: 10.1016/j.clinbiochem.2015.08.003
– volume: 82
  start-page: 718
  year: 2012
  ident: 552_CR12
  publication-title: Kidney Int
  doi: 10.1038/ki.2012.195
– volume: 42
  start-page: 653
  year: 2014
  ident: 552_CR22
  publication-title: Am J Infect Control
  doi: 10.1016/j.ajic.2014.02.003
– volume: 191
  start-page: 1454
  year: 2014
  ident: 552_CR18
  publication-title: J Urol
  doi: 10.1016/j.juro.2013.12.013
– volume: 12
  start-page: e0171114
  year: 2017
  ident: 552_CR20
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0171114
– volume: 50
  start-page: 625
  year: 2010
  ident: 552_CR3
  publication-title: Clin Infect Dis
  doi: 10.1086/650482
– volume: 50
  start-page: 1376
  year: 2012
  ident: 552_CR7
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.05852-11
– volume: 70
  start-page: 376
  year: 1989
  ident: 552_CR4
  publication-title: Arch Phys Med Rehabil
– volume: 25
  start-page: 214
  year: 2019
  ident: 552_CR16
  publication-title: Top Spinal Cord Inj Rehabil
  doi: 10.1310/sci2503-214
– volume: 42
  start-page: 377
  year: 2009
  ident: 552_CR19
  publication-title: J Biomed Inf
  doi: 10.1016/j.jbi.2008.08.010
– volume: 26
  start-page: 1263
  year: 2011
  ident: 552_CR15
  publication-title: Pediatr Nephrol
  doi: 10.1007/s00467-011-1856-3
– volume: 24
  start-page: 2387
  year: 2009
  ident: 552_CR26
  publication-title: Pediatr Nephrol
  doi: 10.1007/s00467-009-1279-6
– volume: 30
  start-page: 123
  year: 2015
  ident: 552_CR14
  publication-title: Pediatr Nephrol
  doi: 10.1007/s00467-014-2905-5
– volume: 51
  start-page: 784
  year: 2013
  ident: 552_CR21
  publication-title: Spinal Cord
  doi: 10.1038/sc.2013.77
– volume: 45
  start-page: 1016
  year: 2013
  ident: 552_CR2
  publication-title: J Rehabil Med
  doi: 10.2340/16501977-1207
– volume: 124
  start-page: 2963
  year: 2014
  ident: 552_CR24
  publication-title: J Clin Invest
  doi: 10.1172/JCI71630
– volume: 18
  start-page: 407
  year: 2007
  ident: 552_CR25
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2006080882
– volume: 99
  start-page: 219
  year: 2018
  ident: 552_CR8
  publication-title: Arch Phys Med Rehabil
  doi: 10.1016/j.apmr.2017.10.005
– ident: 552_CR13
  doi: 10.1681/ASN.2009010065
– volume: 10
  year: 2012
  ident: 552_CR6
  publication-title: J Transl Med
  doi: 10.1186/1479-5876-10-174
– volume: 13
  start-page: e0197568
  year: 2018
  ident: 552_CR9
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0197568
– volume: 33
  start-page: 1365
  year: 2018
  ident: 552_CR17
  publication-title: Pediatr Nephrol
  doi: 10.1007/s00467-018-3936-0
– volume: 15
  start-page: 155.e1
  year: 2019
  ident: 552_CR27
  publication-title: J Pediatr Urol
  doi: 10.1016/j.jpurol.2018.12.008
– volume: 30
  start-page: 956
  year: 2016
  ident: 552_CR23
  publication-title: J Clin Lab Anal
  doi: 10.1002/jcla.21962
– volume: 76
  start-page: 272
  year: 1995
  ident: 552_CR1
  publication-title: Arch Phys Med Rehabil
  doi: 10.1016/S0003-9993(95)80615-6
SSID ssj0009198
Score 2.350796
Snippet Study design Secondary analysis of urine samples collected from a prospective within-subject clinical trial. Objectives Describe the baseline variation in...
Study designSecondary analysis of urine samples collected from a prospective within-subject clinical trial.ObjectivesDescribe the baseline variation in urine...
Secondary analysis of urine samples collected from a prospective within-subject clinical trial.STUDY DESIGNSecondary analysis of urine samples collected from a...
SourceID pubmedcentral
proquest
crossref
springer
SourceType Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 959
SubjectTerms 692/53/2421
692/699/2768/1865
Adults
Anatomy
Biomedical and Life Sciences
Biomedicine
Clinical trials
Gelatinase
Human Physiology
Leukocytes (neutrophilic)
Lipocalin
Neurochemistry
Neuropsychology
Neurosciences
Neutrophils
Secondary analysis
Urinary tract
Urine
Urogenital system
Title The association between urine neutrophil gelatinase-associated lipocalin and UTI in people with neurogenic lower urinary tract dysfunction
URI https://link.springer.com/article/10.1038/s41393-020-00552-x
https://www.proquest.com/docview/2565277372
https://www.proquest.com/docview/2445426624
https://pubmed.ncbi.nlm.nih.gov/PMC11702270
Volume 59
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEB7aBEovpU_qNg0q9NaKWPJLPpW2JKSFhlI2sDejlxvDot3seiH5C_3V1cjymg00N4Nky2gkzWjmm_kAPkh_oa5TLmlVp4rmTFgqtGJUyEpIJZS_dYVqnxfl-WX-Y17Mo8NtE2GV45kYDmqz1OgjP_GqueAVkqp8Xl1TZI3C6Gqk0HgIh1i6DCFd1byaiu6ywIXLhsygOotJM2kmTjb-8EbkGse86qLg9GZfMU3W5l2s5J2AadBDZ0_hSTQgyZdB4s_ggXXP4dHPGCJ_AX-94ImcJp1EJBZBt7olzm779XJ11S3In4CDc16N0bG_NWTRrVC9dY5IZ8jl7DvxjwPOnKDTloQKmH7ZdZoskGItfFiub0mPCVfE3G5QV-LQL2F2djr7dk4j4QLVecF7yllrrGRCZy0ruapN2-pKWX8FkSUyT_ndLaTMmCyEtZk1VislmTG6VW1hZPYKDtzS2ddAvDHcmtpmZanKXAnfblpuuFBlldpa8ATYONmNjsXIkRNj0YSgeCaaQUCNF1ATBNTcJPBx985qKMVxb--jUYZN3JabZlpECbzfNfsNhVES6exy6_vkeYFmC88TEHuy342KJbn3W1x3FUpzI48P51WawKdxmUyj__9n39z_s2_hMUcoTYC2HcFBv97ad94W6tVxWPDHcPj19OLX73-llw4N
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFD4anQS8IK4ibICR4Amsxc7NeUCIy6aWbRVCnbS3yI4dFqlKuzYV61_gv_Af8XGSRp3E3vYWyY4d5Tv2Ofa5fABvpT1Qpz6XNEl9RUMmDBW5YlTIREgllD11uWqf43h4Fn4_j8534G-XC4Nhld2e6DZqPcvxjvzAquaIJ0iq8ml-SZE1Cr2rHYVGIxbHZv3bHtmWH0ffLL7vOD86nHwd0pZVgOZhxGvKWaGNZCIPChZzleqiyBNlrJ0tY6RXsiIspAyYjIQxgdEmV0oyrfNCFZGWgR32DuyGgT3JDGD3y-H4x8--yi9z5LusSUVKgzZLxw_EwdJqCwyV45jIHUWcXm1rwt68vR6cec1D6xTf0UN40Fqs5HMjYo9gx1SP4e5p65N_An-spBHZo0za0C-C9_iGVGZVL2bzi3JKfrnAu8rqTdr1N5pMyznq07IistLkbDIi9rEJbCd4S0xcyU0r52VOpsjp5gaWizWpMcOL6PUSlTNO_RQmt4HFMxhUs8o8B2Kt70KnJohjFYdK2HZdcM2FihPfpIJ7wLqfneVt9XMk4ZhmzgsfiKwBKLMAZQ6g7MqD95t35k3tjxt773cYZu0-sMx6qfXgzabZrmB0y8jKzFa2TxhGaCfx0AOxhf1mVqwBvt1SlReuFjgSB3Ge-B586MSkn_3_H_vi5o99DfeGk9OT7GQ0Pt6D-xzjeFxc3T4M6sXKvLSGWK1eteJPILvlBfcPCh9O2g
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELfGkCZeEH9F2AAjwRNYrZ1_zgNCiFGtDCYeOqlvlh07W6Qq7dpUrF-Bb8S3485JGnUSe9tbJDt2lDv7zr7f3Y-QdxoO1NlQaJZmQ8MiLh2TueFM6lRqIw2cuny1z7Pk5Dz6Po2ne-RvlwuDsMpuT_QbtZ3neEc-ANMcixRJVQZFC4v4dTz6vLhiyCCFkdaOTqNRkVO3-Q3Ht9Wn8THI-r0Qo2-TryesZRhgeRSLmgleWKe5zMOCJ8Jktijy1DjwuXWCVEugzlLrkOtYOhc663JjNLc2L0wRWx3CsPfI_TSMOS6xdJr29X65p-HlTVJSFrb5OsNQDlZgNxA0JzClO44Fu961ib2jexOmeSNW603g6BF52Pqu9EujbI_JnquekIOfbXT-KfkDOkd1L2_agsAo3ug7Wrl1vZwvLssZvfAQvAosKOv6O0tn5QIta1lRXVl6PhlTeGwg7hTvi6kvvgkaX-Z0huxufmC93NAac72o3azQTOPUz8jkLiTxnOxX88q9IBT88MJmLkwSk0RGQrsthBXSJOnQZVIEhHc_W-VtHXSk45gpH48PpWoEpEBAygtIXQfkw_adRVMF5NbeR50MVbsjrFSvvwF5u22GtYwBGl25-Rr6RFGMHpOIAiJ3ZL-dFauB77ZU5aWvCo4UQkKkw4B87NSkn_3_H_vy9o99Qw5gmakf47PTQ_JAIKDHA-yOyH69XLtX4JHV5rXXfUrUHa-1f3oDUao
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+association+between+urine+neutrophil+gelatinase-associated+lipocalin+and+UTI+in+people+with+neurogenic+lower+urinary+tract+dysfunction&rft.jtitle=Spinal+cord&rft.au=ster%2C+Catherine+S&rft.au=Lamanna%2C+Olivia+K&rft.au=Rounds%2C+Amanda&rft.au=Sprague%2C+Bruce+M&rft.date=2021-09-01&rft.pub=Nature+Publishing+Group&rft.issn=1362-4393&rft.eissn=1476-5624&rft.volume=59&rft.issue=9&rft.spage=959&rft.epage=966&rft_id=info:doi/10.1038%2Fs41393-020-00552-x&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1362-4393&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1362-4393&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1362-4393&client=summon